Marubi(603983)

Search documents
丸美生物(603983) - 广东丸美生物技术股份有限公司2024年度环境、社会与公司治理(ESG)报告(英文版)
2025-05-15 08:00
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Guangdong Marubi Biotechnology Co., Ltd. Table of Content | Message from Chairman | 03 | | --- | --- | | About Marubi | 05 | | Recap of 2024 | 11 | | ESG Governance | 15 | | Theme Spotlight: Scientific | 19 | | Skincare, Rejuvenating with | | | Collagen "Core" Innovation | | Appendix 97 | Key Performance Table | 97 | | --- | --- | | Indicators Index | 101 | | About This Report | 105 | Steady Operation, Forging Sustainable "Beauty" Power 01 People-Oriented, Composi ...
丸美生物(603983) - 广东丸美生物技术股份有限公司2024年年度股东大会会议资料
2025-05-15 08:00
广东丸美生物技术股份有限公司 2024 年年度股东大会会议资料 广东丸美生物技术股份有限公司 2024 年年度股东大会 会议资料 2025 年 5 月 22 日 1 广东丸美生物技术股份有限公司 2024 年年度股东大会会议资料 广东丸美生物技术股份有限公司 2024 年年度股东大会会议须知 各位股东及股东代表: 为维护投资者的合法权益,确保广东丸美生物技术股份有限公司(以下简称"公 司")2024 年年度股东大会的顺利召开,依据中国证券监督管理委员会《上市公司 股东大会规则》等有关规定,制定会议须知如下: 一、公司根据《公司法》《证券法》《上市公司股东大会规则》和《公司章程》的 规定,认真做好召开股东大会的各项工作。 二、公司董事会办公室具体负责会议有关程序方面的事宜。 三、为保证股东大会的严肃性和正常秩序,切实维护与会股东(包含股东代表, 下同)的合法权益,除出席会议的股东、公司董事、监事、高级管理人员、公司聘 请的律师及董事会邀请的人员外,公司有权依法拒绝其他人员进入会场。 四、出席会议的股东须在会议召开前 15 分钟到达会议现场向董事会办公室办理 签到手续,并请按规定出示股票账户卡、持股凭证、身份证或 ...
大消费概念持续走高 华业香料等多股涨停
news flash· 2025-05-15 05:48
智通财经5月15日电,大消费概念持续走强,日化、保健品、宠物经济等新消费方向领涨,午后华业香 料、百洋股份涨停,此前金达威、西王食品、交大昂立、若羽臣涨停,青松股份、中草香料、仙乐健 康、丸美生物等涨幅靠前。消息面上,机构指出,当前,国内新消费企业增长强劲,在审美、精神满足 上的升级持续存在,以潮玩、IP文化、宠物等为主的"情感"消费、"体验"消费景气度更是持续上升。 大消费概念持续走高 华业香料等多股涨停 ...
珀莱雅突破百亿、上海家化亏损8亿:国产美妆市场的“洗牌进行时”
3 6 Ke· 2025-05-13 01:56
Core Insights - The performance of domestic beauty companies in China is showing significant divergence, with some achieving remarkable growth while others face declines, indicating a reshaping of the market landscape [1][4][42] Group 1: Company Performance - Proya has become the first domestic beauty company to enter the 10 billion yuan club, with a revenue of 10.778 billion yuan, growing by 21.04% [2] - Other companies like Shangmei and Juzi Biological also reported substantial revenue increases of 62.08% and 57.17% respectively, while Shanghai Jahwa experienced a revenue decline of 13.93% [2][3] - Six beauty companies have revenues exceeding 5 billion yuan, suggesting that this threshold will soon become a significant benchmark for the top 10 domestic beauty brands [1] Group 2: Profitability Trends - Juzi Biological leads in profitability with a profit of 2.062 billion yuan, up 42.06%, while Proya's profit reached 1.552 billion yuan, growing by 30% [3] - In contrast, Shanghai Jahwa reported a loss of 833 million yuan, marking a 266.60% decline, highlighting the stark differences in profitability among companies [3][11] Group 3: Market Dynamics - The current market dynamics indicate a shift towards efficacy-driven products, with companies that successfully launched standout products seeing better performance [4][5] - The competition is intensifying, with new entrants emerging and established brands needing to adapt to changing consumer preferences and market trends [7][30] Group 4: R&D and Strategic Focus - Companies are increasingly focusing on R&D, with most reporting a rise in R&D expenditures, indicating a strategic shift towards innovation and efficacy [20][21] - The trend of acquisitions and investments in technology is becoming a key strategy for companies aiming to enhance market share and scale [23][24] Group 5: Emerging Opportunities - The male skincare market is growing rapidly, presenting new opportunities for brands to capture this segment [36] - The aging population is creating demand for products targeting older consumers, which remains largely untapped [39] - As online sales plateau, brands are shifting focus to offline channels, indicating a potential new battleground for market share [40]
未知机构:申万美护深圳上市公司见面会及近期调研反馈内需消费崛起国货美妆加速完善产品-20250512
未知机构· 2025-05-12 01:55
Summary of Conference Call Records Industry Overview - The beauty and personal care industry in China is experiencing significant growth, driven by domestic consumption and the expansion of domestic brands [1][2]. Key Company Insights Shangmei Co., Ltd. (上美股份) - **Sales Growth**: - Tmall sales increased by 30% - JD.com sales grew nearly 70% - Kuaishou and Pinduoduo saw growth between 150% to 200% [1] - **NewPage Performance**: - Q1 revenue reached 160 million, with a 100% growth rate - Expected profit margin improvement for the year [1] - **Product Launches**: - NanBeauty plans to launch mid-to-high-end cosmetics in the second half of the year - Jifang Hair Care is set to expand after obtaining necessary certifications [1] - **Douyin Growth**: - Sales recovery began in April, with an increase in self-broadcasting and improved profit margins [1] - **Marketing Strategy**: - X Peptide aims for a GMV of 1 billion, with new endorsements to enhance marketing effectiveness [1] - Increased brand promotion and collaborations with influencers, including Ding Yuxi as the global ambassador for Han Shu [1] Runben Co., Ltd. (润本股份) - **Revenue Growth**: - Overall revenue increased by approximately 30% in April, with online sales up by about 10% - Significant growth in offline non-platform distribution (toB business) exceeding 50%, particularly in the Sam's Club channel [2] - **Sales Performance**: - Sales in Sam's Club reached over 20 million in April, up from approximately 12 million in March [2] - **Future Projections**: - Anticipates a revenue growth of over 20% in Q2, maintaining a target of 30% growth for both revenue and profit for the first half of the year [2] Marubi Biotechnology Co., Ltd. (丸美生物) - **Q1 Performance**: - Revenue growth of 28% with a net profit increase of 22% [2] - **Annual Targets**: - Aiming for a 32% growth in net profit for the year, referencing the previous year's performance [2] - **Product Sales Forecast**: - Xiaohongbi Eye Cream projected to achieve over 500 million in sales for 2024, representing a 146% growth - Xiaojin Needle expected to reach 350 million in online sales, with a 96% increase, alongside a doubling of offline sales [2] Additional Insights - The emphasis on high-quality ingredients and effective products is becoming a key profitability driver for companies in the beauty sector [3]
品牌工程指数 上周涨1.99%
Zhong Guo Zheng Quan Bao· 2025-05-11 20:26
Market Performance - The market rebounded last week, with the China Securities Index rising by 1.99% to 1650.47 points [1][2] - The Shanghai Composite Index increased by 1.92%, the Shenzhen Component Index by 2.29%, and the ChiNext Index by 3.27% [2] Strong Stock Performances - Notable strong performers included: - Zhongji Xuchuang (300308) up by 13.55% - Shanghai Jahwa (600315) up by 9.31% - AVIC Shenyang Aircraft (600760) up by 8.25% - CATL (300750) up by 7.24% - Beitaini (300957) up by 6.01% [2] - Other stocks such as Hisense Home Appliances (000921), EVE Energy (300014), and Stone Technology saw gains exceeding 5% [2] Year-to-Date Stock Performance - Since the beginning of 2025, Shanghai Jahwa has surged by 51.39%, leading the gains [3] - Marumi Bio (603983) follows with a 50.59% increase, while Xintai (002294) and Anji Technology have both risen over 30% [3] Market Outlook - Positive factors are emerging as the market stabilizes, with expectations for gradual recovery in investor sentiment and stock performance [4] - The domestic economy is on a steady recovery path, supported by ongoing policy efforts [4] - The current A-share market is viewed as being in a high cost-performance zone, indicating medium to long-term investment value [4] - However, short-term market movements may remain volatile unless strong driving factors emerge [4]
3230.19万元资金今日流出美容护理股
Zheng Quan Shi Bao Wang· 2025-05-09 15:45
Market Overview - The Shanghai Composite Index fell by 0.30% on May 9, with seven industries experiencing gains, led by the beauty and personal care sector, which rose by 1.41% [1] - The electronic and computer sectors faced the largest declines, with drops of 2.07% and 1.96% respectively [1] Capital Flow Analysis - The main capital outflow from the two markets totaled 47.4 billion yuan, with only four industries seeing net inflows [1] - The textile and apparel industry had the highest net inflow, amounting to 226 million yuan, while the coal industry saw a modest increase of 0.10% with a net inflow of 18.6 million yuan [1] Beauty and Personal Care Sector - The beauty and personal care industry saw a rise of 1.41%, despite a net outflow of 32.3 million yuan in main capital [2] - Out of 31 stocks in this sector, 18 experienced gains, including one stock that hit the daily limit [2] - The top three stocks with net inflows were Beitaini (35.1 million yuan), Proya (23.1 million yuan), and Shuiyang (13.7 million yuan) [2][3] Notable Stocks in Beauty and Personal Care - Qingdao Kingking had the largest net outflow at 40.9 million yuan, followed by Runben (8.7 million yuan) and Kesi (8.4 million yuan) [2] - Other notable stocks with significant net outflows included Marubi (8.0 million yuan) and Aimeike (7.5 million yuan) [2] - The stock performance varied, with some stocks like Beitaini and Shuiyang showing strong gains, while others faced significant outflows [2][3]
从品类到品质,从品质到品牌
China Securities· 2025-05-09 01:20
Investment Rating - The report maintains a rating of "Outperform the Market" for the industry [3]. Core Insights - The industry fundamentals are expected to remain under pressure in 2024, with most sectors and companies still significantly affected by macroeconomic factors. However, a number of companies are emerging that are successfully navigating the challenges of consumer downgrade by upgrading from categories to quality and then to brand [1][2]. - The report highlights that companies with strong brand attributes are likely to continue outperforming as the market transitions from price-performance to quality-price comparisons [2]. Summary by Sections 1. Duty-Free Sector - The duty-free sales in Hainan are gradually stabilizing, with the implementation of the Hainan closure policy expected to benefit the duty-free sector. The market is seeing improvements in channel and supply chain capabilities, leading to a stable outlook for profitability [2][49]. - Key companies to watch include China Duty Free Group and Wangfujing [2]. 2. Tourism and Gaming - The tourism sector shows strong resilience in demand, becoming a crucial driver for domestic consumption. The recovery in inbound and outbound travel is significant, with a focus on new consumption scenarios and the silver-haired tourism market [2][3]. - Recommended companies include Jiuhua Tourism, Lingnan Holdings, and Sands China [2]. 3. Hotel Industry - The hotel sector is experiencing weak business travel demand, leading to pressure on RevPAR. However, leisure demand remains resilient, and leading companies are enhancing profitability through brand matrix validation and supply chain optimization [3][72]. - Companies to focus on include Huazhu Group, Atour, and Jinjiang Hotels [3]. 4. Restaurant Sector - Leading restaurant companies are demonstrating strong supply chain negotiation and profitability advantages. The overall supply in the restaurant industry is optimizing, with a competitive trend in price-performance [3][7]. - Notable companies include Mixue Ice City, KFC, and Haidilao [3][7]. 5. Cosmetics and Medical Aesthetics - The cosmetics sector is seeing a shift in focus towards profitability, with companies restructuring their product and channel strategies. High-growth companies are expected to achieve both revenue and profit increases [7][23]. - Key players include Juzhibio, Shumei, and Marubi [7][23]. 6. General Retail - The retail sector is undergoing digital upgrades and operational adjustments, with a focus on essential demand and cash flow stability. Companies like Yonghui Supermarket and Multi-Point Intelligence are recommended [8][30]. - The report also highlights the ongoing challenges in the jewelry sector due to rising gold prices [8][30]. 7. Overall Market Performance - The consumer services sector is expected to face challenges, with a projected performance of -8.70% in 2024. However, the beauty and personal care sector is anticipated to recover with a growth of +8.15% in 2025 [11][19].
丸美生物(603983) - 广东丸美生物技术股份有限公司关于召开2024年年度股东大会的通知
2025-04-30 12:17
证券代码:603983 证券简称:丸美生物 公告编号:2025-014 广东丸美生物技术股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一)股东大会类型和届次 2024年年度股东大会 (二)股东大会召集人:董事会 至2025 年 5 月 22 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00;通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票,应按照《上海证券交易所上市公司自律监管指引第 1 号 — 规范运作》等有 关规定执行。 (七)涉及公开征集股东投票权 (三)投票方式:本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开 ...
国货美妆十强榜单揭晓:百亿时代,谁在引领变革?
FBeauty未来迹· 2025-04-30 09:27
2 0 2 4年在国货美妆发展史上是值得记录一年: 一方面,国内诞生首个突破百亿美妆企业,珀莱雅以1 0 7 . 7 8亿元营收首次跻身"百亿俱乐部", 成 为 行 业 里 程 碑 事 件 ; 同 时 , 十 强 门 槛 抬 高 至 近 3 0 亿 元 , 前 十 总 营 收 规 模 扩 大 至 5 4 3 . 7 7 亿 元。 另一方面,前十座次发生较大变化,毛戈平首次闯入榜单,上海家化、华熙生物等企业持续步 入变革期深水区,迎来业绩"震荡"。 在"突飞猛进"与震荡调整并存的阶段,头部国货企业的发展预示着行业怎样的未来? 综 合 2 0 2 1 年 至 2 0 2 4 年 国 货 美 妆 上 市 企 业 十 强 榜 单 情 况 来 看 , 可 以 发 现 , 名 次 发 生 了 较 大 变 化。每一年的前三名都不相同,并且持续有"突围者"闯入榜单,例如2 0 2 4年的毛戈平。 | | | | 2021年至2024年国货美妆上市企业十强榜单 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | -- ...